Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: Potential diagnostic and prognostic markers and therapeutic targets

被引：30

作者：

Zhang, Qi ^{[1
]}

Pu, Rui ^{[1
]}

Du, Yan ^{[1
]}

Han, Yifang ^{[1
]}

Su, Tong ^{[1
]}

Wang, Hongyang ^{[2
]}

Cao, Guangwen ^{[1
]}

机构：

[1] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Epidemiol, Shanghai 200433, Peoples R China

[2] Eastern Hepatobiliary Surg Inst Hosp, Int Cooperat Lab Signal Transduct, Shanghai, Peoples R China

来源：

CANCER LETTERS | 2012年 / 321卷 / 01期

关键词：

Hepatitis virus; Hepatocellular carcinoma; Non-coding RNA; Biomarker; Therapeutic target; VIRUS X PROTEIN; REGULATES G(1)/S TRANSITION; MICRORNA EXPRESSION; LIVER-CANCER; FUNCTIONAL POLYMORPHISM; CELL-PROLIFERATION; UP-REGULATION; DOXORUBICIN SENSITIVITY; TURKISH POPULATION; HEME OXYGENASE-1;

D O I：

10.1016/j.canlet.2012.03.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Non-coding RNA (ncRNA), a class of RNAs that do not code protein but have regulatory functions, can regulate gene expression and replication of hepatitis B virus or hepatitis C virus and play an important role in the virus-host interaction and the development of hepatocellular carcinoma (HCC). Deregulated ncRNAs in surgically removed hepatic tissues and circulation can be prognostic and diagnostic markers, respectively. ncRNAs functioning as either tumor suppressors or oncogenes can be therapeutic options. Here, we summarize the deregulated ncRNAs associated with the infections and HCC and focus on their roles on early diagnosis, prognosis prediction and therapeutic option of HCC. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

引用

页码：1 / 12

页数：12

共 50 条

[21] Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
Xia, Haoming
Huang, Ziyue
Liu, Shuqiang
Zhao, Xudong
He, Risheng
Wang, Zhongrui
Shi, Wenguang
Chen, Wangming
Li, Zhizhou
Yu, Liang
Huang, Peng
Kang, Pengcheng
Su, Zhilei
Xu, Yi
Yam, Judy Wai Ping
Cui, Yunfu
FRONTIERS IN ONCOLOGY, 2021, 11
[22] NON-CODING RNAs AS POTENTIAL TARGETS AND TOOLS IN PRESENT DIAGNOSTIC AND THERAPY
Sosinska, Patrycja
Zaorska, Katarzyna
POSTEPY BIOLOGII KOMORKI, 2014, 41 (02) : 243 - 264
[23] Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas
Sun, Yuanzhao
Wang, Zhong
Zhou, Dai
MEDICAL HYPOTHESES, 2013, 81 (02) : 319 - 321
[24] Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets
Hashemi, Mehrdad
Mirzaei, Sepideh
Zandieh, Mohammad Arad
Rezaei, Sahar
Kakavand, Amirabbas
Dehghanpour, Amir
Esmaeili, Negin
Ghahremanzade, Azin
Saebfar, Hamidreza
Heidari, Hajar
Salimimoghadam, Shokooh
Taheriazam, Afshin
Entezari, Maliheh
Seok, Kwang
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2023, 177 : 207 - 228
[25] Long non-coding RNAs in immune regulation and their potential as therapeutic targets
Kumar, Dinesh Babu Uthaya
Williams, Adam
INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81
[26] Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
Han, Qin
Wang, Mengchen
Dong, Xi
Wei, Fei
Luo, Yun
Sun, Xiaobo
FRONTIERS IN IMMUNOLOGY, 2022, 13
[27] The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma
Moyo, Buhle
Nicholson, Samantha A.
Arbuthnot, Patrick B.
VIRUS RESEARCH, 2016, 212 : 103 - 113
[28] Long non-coding RNAs in hepatocellular carcinoma
Ge, Wen-jun
Huang, Huan
Wang, Tao
Zeng, Wei-hong
Guo, Min
Ren, Chen-ran
Fan, Ting-yu
Liu, Fang
Zeng, Xi
PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
[29] Pathogenesis of hepatitis C-associated hepatocellular carcinoma
Liang, TJ
Heller, T
GASTROENTEROLOGY, 2004, 127 (05) : S62 - S71
[30] Long non-coding RNAs as novel diagnostic and therapeutic targets in kidney disease
ZhouQin
ChenWei
YuXue-Qing
慢性疾病与转化医学（英文）, 2019, (04) : 252 - 257

← 1 2 3 4 5 →